CNN senior congressional reporter, Manu Raju, on healthcare, meetings with Russians and other Washington news stories, then, how smart phones could be used to help treat diagnose and treat mental illness
The Vioxx recall is just the latest of several episodes this year that have prompted criticism of the FDA and Senate hearings. A panel talks about the drug approval process, post-marketing safety surveillance, and how the agency’s work affects Americans’ health and safety.
- Marc Kaufman Reporter on the national desk of "The Washington Post"
- Dr. Jerry Avorn Author of "Powerful Medicines," professor of medicine at Harvard Medical School, and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston
- Alan Goldhammer, PhD Associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
- Sen. Charles Grassley (R-Iowa), ranking member of the Senate Finance Committee
- Dr. Sandra Kweder Deputy director of the FDA's Office of New Drugs
Most Recent Shows
Two perspectives on the magnitude of the the opioid addiction crisis we face in this country, then, what a new play based on Supreme Court Justice Antonin Scalia teaches us about political polarization and compromise.
Financial Times columnist Ed Luce explains what has given rise to populism in the West. Then, a Georgetown professor on the parallels between Charlotte Bronte's life and that of her famous protagonist Jane Eyre.
Fast action at the EPA on President Trump's pledge to roll back environmental regulations, then, epic swimmer Diane Nyad on the many benefits of walking.